Clicky

Astrazeneca PLC(AZN) News

Date Title
Apr 5 Pharma Stock Roundup: AZN Voydeya Gets FDA Nod, MRK KRAS Inhibitor Enters Phase III
Apr 5 IMFINZI® (durvalumab) significantly improved overall survival and progression-free survival for patients with limited-stage small cell lung cancer in ADRIATIC Phase III trial
Apr 5 ‘Pioneering’ lung cancer drug offers hope for patients
Apr 5 Trending tickers: AMD, Shell, AstraZeneca, HubSpot
Apr 5 UPDATE 2-AstraZeneca's Imfinzi improves survival in late-stage lung cancer trial
Apr 3 Biden and Senator Sanders to highlight efforts lower cost of asthma inhalers
Apr 2 Are You Looking for a High-Growth Dividend Stock?
Apr 2 AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance
Apr 2 AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod
Apr 2 Datopotamab deruxtecan Biologics License Application accepted in the US for patients with previously treated metastatic HR-positive, HER2-negative breast cancer
Apr 2 Datopotamab Deruxtecan Biologics License Application Accepted in the U.S. for Patients with Previously Treated Metastatic HR Positive, HER2 Negative Breast Cancer
Apr 1 Astrazeneca (AZN) Sees a More Significant Dip Than Broader Market: Some Facts to Know
Apr 1 VOYDEYA™ approved in the US as add-on therapy to ravulizumab or eculizumab for treatment of extravascular hemolysis in adults with the rare disease PNH
Apr 1 AstraZeneca PLC's (LON:AZN) Stock Is Going Strong: Have Financials A Role To Play?
Apr 1 AstraZeneca gets FDA OK for rare disease drug acquired in Alexion buyout
Mar 30 20 Countries with the Highest Age Dependency Ratio in the World
Mar 28 Pharma Stock Roundup: ABBV & NVO's New M&As, FDA Nod to JNJ & MRK PAH Drugs
Mar 28 7 Blue-Chip Stocks That Will Outperform the Dow in the 5 Five Years
Mar 27 Viking (VKTX) Up 17% on Encouraging Oral Obesity Drug Data
Mar 26 AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication